These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23778569)

  • 21. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
    Taniguchi M
    Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data.
    Pelletier SJ; Fu S; Thyagarajan V; Romero-Marrero C; Batheja MJ; Punch JD; Magee JC; Lok AS; Fontana RJ; Marrero JA
    Liver Transpl; 2009 Aug; 15(8):859-68. PubMed ID: 19642139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers.
    Wong LL; Tanaka K; Lau L; Komura S
    Clin Transplant; 2004 Jun; 18(3):227-34. PubMed ID: 15142041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver transplantation for hepatocellular carcinoma without preoperative tumor biopsy.
    Compagnon P; Grandadam S; Lorho R; Turlin B; Camus C; Jianrong Y; Lainé F; Meunier B; Deugnier Y; Boudjema K
    Transplantation; 2008 Oct; 86(8):1068-76. PubMed ID: 18946344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the diagnostic accuracy of T2*-weighted MR imaging for identifying hepatocellular carcinoma with liver explant correlation.
    Hardie AD; Nance JW; Boulter DJ; Kizziah MK
    Eur J Radiol; 2011 Dec; 80(3):e249-52. PubMed ID: 21112710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging techniques for the diagnosis of hepatocellular carcinoma and the evaluation of response to treatment.
    Hussain HK; Barr DC; Wald C
    Semin Liver Dis; 2014 Nov; 34(4):398-414. PubMed ID: 25369302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria.
    De Giorgio M; Vezzoli S; Cohen E; Armellini E; Lucà MG; Verga G; Pinelli D; Nani R; Valsecchi MG; Antolini L; Colledan M; Fagiuoli S; Strazzabosco M
    Liver Transpl; 2010 Apr; 16(4):503-12. PubMed ID: 20373461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD.
    Hayashi PH; Trotter JF; Forman L; Kugelmas M; Steinberg T; Russ P; Wachs M; Bak T; Kam I; Everson GT
    Liver Transpl; 2004 Jan; 10(1):42-8. PubMed ID: 14755776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular carcinoma: detection with diffusion-weighted versus contrast-enhanced magnetic resonance imaging in pretransplant patients.
    Park MS; Kim S; Patel J; Hajdu CH; Do RK; Mannelli L; Babb JS; Taouli B
    Hepatology; 2012 Jul; 56(1):140-8. PubMed ID: 22370974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
    Park MJ; Kim YK; Lee MH; Lee JH
    Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ; Lee JM; Lee JY; Kim SH; Kim SJ; Han JK; Choi BI
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity of commonly available screening tests in detecting hepatocellular carcinoma in cirrhotic patients undergoing liver transplantation.
    Gambarin-Gelwan M; Wolf DC; Shapiro R; Schwartz ME; Min AD
    Am J Gastroenterol; 2000 Jun; 95(6):1535-8. PubMed ID: 10894592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database.
    Austin MT; Leys CM; Feurer ID; Lovvorn HN; O'Neill JA; Pinson CW; Pietsch JB
    J Pediatr Surg; 2006 Jan; 41(1):182-6. PubMed ID: 16410130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy.
    Yao FY; Bass NM; Nikolai B; Merriman R; Davern TJ; Kerlan R; Ascher NL; Roberts JP
    Liver Transpl; 2003 Jul; 9(7):684-92. PubMed ID: 12827553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome.
    Shetty K; Timmins K; Brensinger C; Furth EE; Rattan S; Sun W; Rosen M; Soulen M; Shaked A; Reddy KR; Olthoff KM
    Liver Transpl; 2004 Jul; 10(7):911-8. PubMed ID: 15237377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging.
    Krinsky GA; Lee VS; Theise ND; Weinreb JC; Morgan GR; Diflo T; John D; Teperman LW; Goldenberg AS
    Liver Transpl; 2002 Dec; 8(12):1156-64. PubMed ID: 12474156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of treatment response of chemoembolization in hepatocellular carcinoma with diffusion-weighted imaging on 3.0-T MR imaging.
    Sahin H; Harman M; Cinar C; Bozkaya H; Parildar M; Elmas N
    J Vasc Interv Radiol; 2012 Feb; 23(2):241-7. PubMed ID: 22019180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathologic outcome of neoadjuvant image-guided therapy of hepatocellular carcinoma.
    Marin HL; Furth EE; Olthoff K; Shaked A; Soulen MC
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):169-76. PubMed ID: 19565046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?
    Roayaie K; Feng S
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S36-43. PubMed ID: 17969067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.